ArticleScientific reports2026
Linalool exhibits potent antibacterial and anti-biofilm activity against carbapenem-resistant Acinetobacter baumannii.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Acinetobacter baumannii poses an urgent clinical challenge due to its extensive antimicrobial resistance and enhanced capacity for biofilm development. These biofilm structures act as protective barriers that impede antibiotic penetration and shield bacterial cells from immune-mediated clearance, often leading to persistent and hard-to-treat infections. This investigation explored the therapeutic potential of linalool, a naturally occurring monoterpene alcohol, against clinical carbapenem-resistant Acinetobacter baumannii (CRAB) isolates. Linalool demonstrated robust inhibitory effects on both early-stage biofilm formation and the disruption of preformed biofilms, as evidenced through crystal violet staining and live/dead viability imaging via confocal microscopy. Even at sub-inhibitory concentrations where planktonic growth was not fully suppressed, the growth kinetics changed in a dose-dependent manner. In addition, metabolic activity within the biofilms was markedly suppressed following linalool exposure, as determined by XTT reduction assays. At the molecular level, qPCR analysis revealed that linalool downregulated critical virulence- and resistance-associated determinants, including bap, bfmR, csuA/B, ompA, and bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.